This comprehensive care bundle integrates advanced genetic testing with tailored interventions to empower women in understanding and managing their risk for Alzheimer’s disease (AD) and related dementias. NGS gene testing panel analyses
APP, PSEN1, PSEN2 (early-onset AD), and APOE (ε4 allele for late-onset risk. Women face unique risks of higher AD prevalence and gender-informed care enables them to take proactive health decisions. Cascade testing in relatives and preimplantation genetic diagnosis (PIGD) for family planning enables genetic insights into actionable strategies. This panel fosters holistic approach of empowerment and preparedness in the face of Alzheimer’s and dementia.